Glucagon-like peptide 1 (GLP-1) is a peptide hormone that can resensitize insulin signalling, and GLP-1 mimetics are widely used in treating type 2 diabetes [10–12]. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.